Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Shops lining up to win SmithKline's $25 mil Paxil

Published on .

Several agencies are competing for the upcoming, estimated $25 million account for anti-depressant prescription drug Paxil from SmithKline Beecham. McCann-Erickson Worldwide and Jordan McGrath Case & Partners, both New York; and WPP Group's CommonHealth USA, Parsippany, N.J., are in the running to market the drug, which is still awaiting approval from the Food & Drug Administration.

Copyright July 1998, Crain Communications Inc.

Most Popular
In this article: